This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Junhao Yang: Innovator in Interleukin-2 Conjugates
Introduction
Junhao Yang is a prominent inventor based in Milpitas, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. His work focuses on human interleukin-2 conjugates, which have potential applications in cancer treatment.
Latest Patents
Junhao Yang holds a patent for "Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer." This patent describes interleukin-2 (IL-2) conjugates that include amino acid substitutions to enhance binding to the IL-2 receptor βγ dimer over the IL-2 receptor αβγ trimer. The conjugates are designed to be useful in the treatment and prevention of cell proliferation and cancer in patients.
Career Highlights
Junhao Yang is associated with Merck Sharp & Dohme Corporation, where he continues to advance his research and development efforts. His innovative work has led to advancements in therapeutic strategies for cancer treatment.
Collaborations
He collaborates with notable colleagues, including Cristina Abrahams and Edward P. Bowman, who contribute to his research initiatives and projects.
Conclusion
Junhao Yang's contributions to the field of biotechnology, particularly through his patent on interleukin-2 conjugates, highlight his role as an influential inventor. His work has the potential to impact cancer treatment significantly.